{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CLVLF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLVLF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLVLF\",,,,,undefined,":{"symbol":"CLVLF","market":"US","secType":"STK","nameCN":"Clinuvel Pharmaceuticals Ltd.","latestPrice":7.22,"timestamp":1750449600000,"preClose":7.22,"halted":0,"volume":0,"delay":15,"floatShares":41256001,"shares":49946800,"eps":0.476171,"marketStatus":"Closed","change":0,"latestTime":"06-20 16:00:00 EDT Delay","open":7.22,"high":7.22,"low":7.22,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.476171,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":7.22,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLVLF\",,,,,undefined,":{"symbol":"CLVLF","floatShares":41256001,"roa":"14.22%","roe":"19.59%","lyrEps":0.477115,"shares":49946800,"dividePrice":0.045618,"high":7.22,"amplitude":0,"preClose":7.22,"low":7.22,"week52Low":6.9,"pbRate":"2.57","psRate":"6.12","week52High":11.55,"institutionHeld":0,"latestPrice":7.22,"eps":0.476171,"divideRate":0.006318,"volume":0,"delay":15,"ttmEps":0.476171,"open":7.22,"prevYearClose":8.45,"prevWeekClose":7.22,"prevMonthClose":6.95,"prevQuarterClose":7.445,"fiveDayClose":7.22,"twentyDayClose":6.95,"sixtyDayClose":7.445},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CLVLF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLVLF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529587483","title":"Clinuvel Pharmaceuticals Ltd (CLVLF) (H1 2025) Earnings Call Highlights: Strong Revenue Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2529587483","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529587483?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:32","pubTimestamp":1745267545,"startTime":"0","endTime":"0","summary":"Sales Growth: Increased by 10.5% to $36 million.Total Revenues: Grew by 21% to $43 million.Expenses Growth: Contained to a modest 2% increase.Profit Before Tax: Rose by 48% to just under $22 million.Profit After Tax: Increased by almost 30% to $14 million.Earnings Per Share: Increased by 27% from $0.22 to $0.28 per share.Net Assets: Strengthened with a 7% increase since June last year.Cash Reserves: Rose by 8% to $198 million.GuruFocus has detected 2 Warning Signs with CLVLF.Clinuvel Pharmaceuticals Ltd  reported a 10.5% increase in sales to $36 million and a 21% rise in total revenues to $43 million.Clinuvel Pharmaceuticals Ltd  maintained a strong balance sheet with a 7% increase in net assets and an 8% rise in cash reserves to $198 million.Clinuvel Pharmaceuticals Ltd  faces competition in recruiting clinical trials for vitiligo, which may require strategic resource deployment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/clinuvel-pharmaceuticals-ltd-clvlf-h1-203225350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CLVLF","CUV.AU"],"gpt_icon":0},{"id":"2504536469","title":"Clinuvel Pharmaceuticals Limited (CLVLF) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2504536469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504536469?lang=en_us&edition=fundamental","pubTime":"2025-01-19 20:16","pubTimestamp":1737288979,"startTime":"0","endTime":"0","summary":"In a report released on January 17, David Stanton from Jefferies maintained a Buy rating on Clinuvel Pharmaceuticals Limited (CLVLF – Research Repo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/clinuvel-pharmaceuticals-limited-clvlf-receives-a-buy-from-jefferies-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/clinuvel-pharmaceuticals-limited-clvlf-receives-a-buy-from-jefferies-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLVLF"],"gpt_icon":0},{"id":"2479217026","title":"MA Financial Group Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479217026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479217026?lang=en_us&edition=fundamental","pubTime":"2024-10-30 12:35","pubTimestamp":1730262943,"startTime":"0","endTime":"0","summary":"MA Financial Group analyst Sarah Mann maintained a Buy rating on Clinuvel Pharmaceuticals Limited (CLVLF – Research Report) today and set a price t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ma-financial-group-sticks-to-its-buy-rating-for-clinuvel-pharmaceuticals-limited-clvlf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ma-financial-group-sticks-to-its-buy-rating-for-clinuvel-pharmaceuticals-limited-clvlf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLVLF","MA"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLVLF\",params:#limit:5,,,undefined,":[{"date":"2024-09-05","symbol":"CLVLF","amount":0.071429,"announcedDate":"2024-08-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-06","defaultRemindTime":1725543000000,"name":"Clinuvel Pharmaceuticals Ltd.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725508800000,"payDate":"2024-09-20"},{"date":"2023-09-05","symbol":"CLVLF","amount":0.071429,"announcedDate":"2023-08-29","type":"dividend","market":"US","newRecordDate":"2023-09-06","defaultRemindTime":1693920600000,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2023-09-20","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693886400000,"payDate":"2023-09-20"},{"market":"US","date":"2022-09-06","symbol":"CLVLF","amount":0.057143,"defaultRemindTime":1662471000000,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2022-09-21","payableDate":"2022-09-07","currency":"AUD","type":"dividend","dateTimestamp":1662436800000},{"market":"US","date":"2021-09-02","symbol":"CLVLF","amount":0.025,"defaultRemindTime":1630589400000,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2021-09-17","payableDate":"2021-09-03","currency":"AUD","type":"dividend","dateTimestamp":1630555200000},{"market":"US","date":"2020-09-03","symbol":"CLVLF","amount":0.025,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2020-09-18","payableDate":"2020-09-04","currency":"AUD","type":"dividend","dateTimestamp":1599105600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLVLF\",market:\"US\",,,undefined,":[{"executeDate":"2019-09-04","recordDate":"2019-09-05","paymentDate":"2019-09-19","value":0.025,"currency":"AUD"},{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.057143,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.071429,"currency":"AUD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLVLF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1729828800000}}}